Home Cart 0 Sign in  

[ CAS No. 71989-18-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 71989-18-9
Chemical Structure| 71989-18-9
Structure of 71989-18-9 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 71989-18-9 ]

Related Doc. of [ 71989-18-9 ]

Alternatived Products of [ 71989-18-9 ]
Product Citations

Product Citations

Ogawa, Kazuma ; Nishizawa, Kota ; Mishiro, Kenji , et al. DOI:

Abstract: Acidic amino acid peptides have a high affinity for bone. Previously, we demonstrated that radiogallium complex-conjugated oligo-acidic amino acids possess promising properties as bone-seeking radiopharmaceuticals. Here, to elucidate the effect of stereoisomers of Glu in Glu-containing peptides [(Glu)14] on their accumulation in the kidney, the biodistributions of [67Ga]Ga-N,N′ -bis-[2-hydroxy- 5-(carboxyethyl)benzyl]ethylenediamine-N,N′ -diacetic acid-conjugated (L-Glu)14 ([67Ga]Ga-HBED-CC- (L-Glu)14), [67Ga]Ga-HBED-CC-(D-Glu)14, [67Ga]Ga-HBED-CC-(DL-Glu)14, and [67Ga]Ga-HBED-CC- (D-Glu-L-Glu)7 were compared. Although the accumulation of these compounds in the bone was comparable, their kidney accumulation and retention were strikingly different, with [67Ga]Ga-HBED-CC- (D-Glu-L-Glu)7 exhibiting the lowest level of kidney accumulation among these compounds. Repeated D- and L-peptides may be a useful method for reducing renal accumulation in some cases.

Keywords: kidney accumulation ; bone imaging ; ; bone metastases ; gallium

Purchased from AmBeed: ;

Product Details of [ 71989-18-9 ]

CAS No. :71989-18-9 MDL No. :MFCD00037135
Formula : C24H27NO6 Boiling Point : No data available
Linear Structure Formula :C13H9CH2OCONHCHCH2CH2CO2C(CH3)3CO2H InChI Key :OTKXCALUHMPIGM-FQEVSTJZSA-N
M.W : 425.47 Pubchem ID :2724637
Synonyms :

Calculated chemistry of [ 71989-18-9 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 31
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.38
Num. rotatable bonds : 11
Num. H-bond acceptors : 6.0
Num. H-bond donors : 2.0
Molar Refractivity : 115.34
TPSA : 101.93 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.16 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.19
Log Po/w (XLOGP3) : 3.85
Log Po/w (WLOGP) : 4.1
Log Po/w (MLOGP) : 2.77
Log Po/w (SILICOS-IT) : 3.74
Consensus Log Po/w : 3.53

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -4.46
Solubility : 0.0146 mg/ml ; 0.0000344 mol/l
Class : Moderately soluble
Log S (Ali) : -5.69
Solubility : 0.000875 mg/ml ; 0.00000206 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.13
Solubility : 0.000314 mg/ml ; 0.000000738 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 4.35

Safety of [ 71989-18-9 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;